NasdaqGS:PODDMedical Equipment
How Major Omnipod Recalls and Digital Expansion Will Impact Insulet (PODD) Investors
In July 2026, Insulet Corporation initiated multiple voluntary Class I global recalls covering millions of Omnipod DASH, Omnipod 5, and Omnipod (Eros) Pods after discovering a manufacturing defect that could cause insulin leakage and serious hyperglycemic events, while also expanding Omnipod 5 and its Omnipod Discover data platform into Spain and launching a global emotional well-being partnership with Calm for the diabetes community.
These events highlight both the operational risk of...